Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1962 1
1963 2
1964 1
1965 1
1969 1
1970 1
1976 1
1986 1
1990 1
1991 1
1992 3
1993 1
1994 4
1995 1
1998 1
2001 1
2002 1
2004 3
2005 1
2006 6
2007 9
2008 7
2009 11
2010 6
2011 5
2012 3
2013 14
2014 10
2015 18
2016 23
2017 22
2018 12
2019 8
2020 13
2021 9
2022 2
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Results by year

Filters applied: . Clear all
Page 1
A Non-D2-Receptor-Binding Drug for the Treatment of Schizophrenia.
Koblan KS, Kent J, Hopkins SC, Krystal JH, Cheng H, Goldman R, Loebel A. Koblan KS, et al. Among authors: loebel a. N Engl J Med. 2020 Apr 16;382(16):1497-1506. doi: 10.1056/NEJMoa1911772. N Engl J Med. 2020. PMID: 32294346 Clinical Trial.
Lurasidone drug-drug interaction studies: a comprehensive review.
Chiu YY, Ereshefsky L, Preskorn SH, Poola N, Loebel A. Chiu YY, et al. Among authors: loebel a. Drug Metabol Drug Interact. 2014;29(3):191-202. doi: 10.1515/dmdi-2014-0005. Drug Metabol Drug Interact. 2014. PMID: 24825095 Free article. Review.
Lurasidone: a new drug in development for schizophrenia.
Meyer JM, Loebel AD, Schweizer E. Meyer JM, et al. Among authors: loebel ad. Expert Opin Investig Drugs. 2009 Nov;18(11):1715-26. doi: 10.1517/13543780903286388. Expert Opin Investig Drugs. 2009. PMID: 19780705 Review.
182 results